Skip to content

Clinical trials

Completed Phase 1/2 Pancreatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1/2 Status: Completed Clear all

135 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20032
20045
20055
20065
20077
20087
20099
20104
20116
20125
20135
20145
20156
201612
201711
20188
20195
20207
20217
20224
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed135

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fuda Cancer Hospital, Guangzhou5
National Cancer Institute (NCI)5
Gilead Sciences4
Eli Lilly and Company3
NewLink Genetics Corporation3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
Amsterdam UMC, location VUmc2
Bristol-Myers Squibb2
Novartis Pharmaceuticals2
Pancreatic Cancer Research Team2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms135
Colorectal Neoplasms20
Neoplasms20
Colonic Neoplasms18
Breast Neoplasms16
Carcinoma, Non-Small-Cell Lung16
Ovarian Neoplasms15
Stomach Neoplasms11
Esophageal Neoplasms10
Head and Neck Neoplasms9

Trials

Showing 1 to 25 of 135. Each trial links to its page on Pharma Observatory.

35 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.